Physician profile
Benjamin P Marquez
NPI 1235147182
$9,238.16
in general payments reported to CMS, 2019-2025
54 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $993 · 2020: $1,055 · 2021: $1,897 · 2022: $1,336 · 2023: $1,367 · 2024: $1,162 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,957.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $781.65 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $682.86 | 2021-2025 | |
| Lilly USA, LLC | $667.81 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $642.08 | 2019-2025 | Xifaxan |
| Pfizer INC. | $620.57 | 2019-2025 | |
| Amgen INC. | $597.89 | 2019-2025 | Evenity, Otezla, Repatha |
| Astellas Pharma US INC | $554.26 | 2019-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $421.53 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $381.55 | 2021-2025 | |
| Esperion Therapeutics, INC. | $370.24 | 2021-2025 | Nexletol |
| Sumitomo Pharma America, INC. | $296.96 | 2023-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $232.43 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $231.08 | 2019-2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $208.20 | 2019-2025 | Rexulti |
| Amarin Pharma, INC. | $207.53 | 2019-2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $205.14 | 2020-2022 | |
| Abbott Laboratories | $196.64 | 2020-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $189.92 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Exact Sciences Corporation | $186.60 | 2023-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $177.68 | 2020-2025 | Austedo Xr |
| Dexcom, INC. | $132.78 | 2021-2025 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $127.42 | 2022-2023 | Yupelri |
| Sunovion Pharmaceuticals INC. | $97.19 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $95.16 | 2022-2024 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.12 | 2019-2025 | Jardiance |
| Allergan, INC. | $62.92 | 2019-2020 | |
| Eisai INC. | $59.43 | 2020-2021 | |
| Axonics, INC. | $46.48 | 2021 | |
| Nevro Corp. | $45.27 | 2022-2023 | Senza |
| Kowa Pharmaceuticals America, INC. | $44.62 | 2019-2021 | |
| Si-Bone, INC. | $44.05 | 2023-2024 | |
| Ibsa Pharma INC. | $39.03 | 2020-2023 | Tirosint, Licart |
| Philips North America LLC | $37.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.31 | 2019 | |
| Aytu Biopharma, INC. | $31.69 | 2019 | |
| Smith+Nephew, INC. | $30.81 | 2022-2024 | Collagenase Santyl |
| Sanofi-Aventis U.S. LLC | $30.61 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $30.23 | 2024 | Ryaltris |
| Lundbeck LLC | $27.94 | 2024-2025 | Rexulti |
| Organogenesis INC. | $27.77 | 2021 | |
| Jazz Pharmaceuticals INC. | $23.16 | 2020 | |
| Averitas Pharma INC. | $21.90 | 2023 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $21.34 | 2022 | |
| Painteq LLC | $21.21 | 2024 | Painteq |
| Biotronik Nro, INC. | $20.05 | 2025 | Prospera |
| Medtronic, INC. | $19.52 | 2021 | |
| Lucid Diagnostics INC. | $19.51 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $19.03 | 2021 | |
| Daiichi Sankyo INC. | $15.95 | 2020 | |
| Horizon Therapeutics Plc | $15.23 | 2019 | |
| Saluda Medical Americas, INC. | $14.75 | 2024 | Evoke |
| Vertiflex, INC. | $12.89 | 2019 | |
| Medtronic USA, INC. | $11.58 | 2020 | |
| Antares Pharma, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.